Bodmer Mark
CIK 0001738885
CSO, President of R&D
Filings
9
Latest Nov 8, 2023
Issuers covered
1
Showing
9 of 9
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 40% | +0.0% | -6.6% | +32.4% | -29.2% |
| 90 days | 5 | 60% | -42.0% | +83.9% | +96.3% | -327.6% |
| 180 days | 5 | 100% | +87.0% | +85.6% | +99.6% | +79.7% |
| 365 days | 5 | 100% | +99.6% | +99.9% | +100.0% | +98.1% |
Issuers
Companies where Bodmer Mark has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| EVLO | Evelo Biosciences, Inc. | 9 | Nov 8, 2023 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|